EMA recommends fexinidazole, the first all-oral treatment for sleeping sickness

(Drugs for Neglected Diseases Initiative) The positive opinion is the result of a 10-year partnership between the Drugs for Neglected Diseases initiative (DNDi), Sanofi, and African partners. Fexinidazole will support international efforts to eliminate sleeping sickness, a fatal neglected tropical disease endemic to Africa.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news